Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
TUTI-16 in Asymptomatic HIV-1 Infected Subjects
NCT01335191Phase 2Completed
- Sponsor
- Thymon
- Start
- Jun 2011
- Primary completion
- Jun 2012
- Modality
- Cyclic Peptides, Vaccines & Immunotherapeutics, Peptide Conjugates
- Countries
- 1
01
Overview
A Phase 2 trial of TUTI-16 in human immunodeficiency virus infection (HIV), sponsored by Thymon. Started Jun 2011; status: completed.
02
Drugs
TUTI-16
03
Conditions
human immunodeficiency virus infection (HIV)
Beyond the preview
Go deeper on NCT01335191.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on NCT01335191.